2405 Wesbrook Mall, Fourth Floor
Member Sector: Academic & Research Institutions
The Centre for Drug Research and Development (CDRD) addresses one of the biggest challenges facing the life sciences sector today: how to translate commercially promising health research conducted at the university level into new therapies that improve and save lives.
CDRD is a national, not-for-profit drug development and commercialization centre that de-risks discoveries stemming from publicly funded research to create viable investment opportunities for the private sector â€” thereby bridging the commercialization gap between early-stage academic research and industry.
CDRD was born of a shared vision between government, industry and academia. We were founded in 2007 as an independent, not-for-profit organization by a group of renowned academic investigators and business people with proven track records in creating new medicines. Just one year later, we were recognized by the Government of Canada as a national Centre of Excellence in Commercialization and Research.
Over the last half decade, CDRD has leveraged public and private sector funding to create a state-of-the-art drug development and commercialization platform with the infrastructure, scientific and business expertise and professional project management skills to develop innovative health technologies through the pre-clinical stage. To date, CDRD has undertaken over 100 research projects (80 technologies), launched a new start-up company and out-licensed or optioned six novel therapies.
CDRD provides one-stop, structured access to multiple research institutions, and produces a continuous pipeline of pre-validated and de-risked technologies that can be efficiently and cost-effectively brought to market. Our single mandate of commercialization results in cost-efficient collaboration and development using CDRD’s existing networks, facilities, and infrastructure.
Our for-profit arm, CDRD Ventures Inc. (CVI), acts as the interface between CDRD and industry to drive drug development and technology commercialization further. CVI in-licenses selected intellectual property generated from CDRD projects directly from the affiliated institution or inventor, and forms strategic partnerships with pharmaceutical and biotechnology companies to transform promising drug research into much-needed medical therapeutics. Profits from CVI flow back to CDRD to support future drug development projects.
We invite you to join us in this collaborative approach to meeting the health challenges of the next decade.